Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-01

Clinical Trial Update: Marshall Ethanolization, Pulmonary Vein Isolation and Line Completion for Ablation of Persistent Atrial Fibrillation [NA]

View source ↗

Summary

An active, not-recruiting clinical trial is evaluating ethanol-based ablation for persistent atrial fibrillation, including pulmonary vein isolation and ablatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Atrial Fibrillation | NA | Status: ACTIVE_NOT_RECRUITING